Jane Xu

Biographical Sketch

Dr. Jane Xu is Executive Director, Biostatistics and Data Management at Sunovion Pharmaceuticals Inc. She has built the Biostatics and Data Management team at the Fort Lee site and her team has played a key role in the Latuda NDA submission which has gained first cycle of approval for the treatment of schizophrenia in October, 2010.

Before joining Sunovion, Dr. Xu was with Novartis for more than 7 years, worked on CNS area drugs for treatments of schizophrenia, bipolar, majoy depression disorder, Parkinson dementia disease etc. Prior to Novartis, Dr. Xu worked for GSK for two years on anti-diabetic drugs.

Dr. Xu holds a Ph.D. in Biostatistics from the Johns Hopkins University, a M.S. in Statistics and Decision Sciences from Duke University. She also has a B.S. in Probability and Statistics from Beijing University.

Instant Short Conference

Dr. Xu has contributed to the following Instant Short Conference:


Browse the catalog of Instant Conferences and Instant Short Courses.

© 2008-2020 Supremum Group. All Rights Reserved.
Supremum Group | Terms of Use | Privacy Policy | Contact